Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomised, multicentre trial.
作者： C N Mallinson , M O Rake , J B Cocking , C A Fox , M T Cwynarski
DOI: 10.1136/BMJ.281.6255.1589
关键词: Vincristine 、 Pancreatic cancer 、 Medicine 、 Regimen 、 Surgery 、 Randomized controlled trial 、 Fluorouracil 、 Cyclophosphamide 、 Chemotherapy 、 Radiation therapy 、 General Medicine
摘要: … pancreatic cancer were included ina prospective, randomised, controlled trial of multiple chemotherapy. … favourably with previous reports of chemotherapy with or without radiotherapy. If …
highwire.org参考文章(10)
Philip S. Schein, Philip T. Lavin, Charles G. Moertel, Stephen Frytak, Richard G. Hahn, Michael J. O'Connell, Richard J. Reitemeier, Joseph Rubin, Allen J. Schutt, Louis H. Weiland, M. Kalser, J. Barkin, H. Lessner, R. Mann-Kaplan, D. Redlhammer, M. Silverman, M. Troner, H. O. Douglass, S. Milliron, J. Lokich, J. Brooks, J. Chaffe, A. Like, N. Zamcheck, K. Ramming, J. Bateman, H. Spiro, E. Livstone, A. Knowlton, Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin‐d in advanced measurable pancreatic carcinoma. A gastrointestinal tumor study group report Cancer. ,vol. 42, pp. 19- 22 ,(1978) , 10.1002/1097-0142(197807)42:1<19::AID-CNCR2820420103>3.0.CO;2-4
Charles G. Moertel, Harold O. Douglas, James Hanley, Paul P. Carbone, Treatment of advanced adenocarcinoma of the pancreas with combinations of streptozotocin plus 5-fluorouracil and streptozotocin plus cyclophosphamide Cancer. ,vol. 40, pp. 605- 608 ,(1977) , 10.1002/1097-0142(197708)40:2<605::AID-CNCR2820400202>3.0.CO;2-#
R Peto, M C Pike, P Armitage, N E Breslow, D R Cox, S V Howard, N Mantel, K McPherson, J Peto, P G Smith, Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. British Journal of Cancer. ,vol. 35, pp. 1- 39 ,(1977) , 10.1038/BJC.1977.1
Stephen K. Carter, Robert L. Comis, The integration of chemotherapy into a combined modality approach for cancer treatment Cancer Treatment Reviews. ,vol. 2, pp. 193- 214 ,(1975) , 10.1016/S0305-7372(75)80003-X
R. Glen Wiggans, Paul V. Woolley, John S. Macdonald, Tarilyn Smythe, Winston Ueno, Philip S. Schein, Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer. Cancer. ,vol. 41, pp. 387- 391 ,(1978) , 10.1002/1097-0142(197802)41:2<387::AID-CNCR2820410201>3.0.CO;2-X
Thomas Buroker, P. N. Kim, Carl Groppe, Joseph McCracken, Robert O'Bryan, Frank Panettiere, John Costanzi, Richard Bottomley, G. W. King, John Bonnet, Tate Thigpen, J. Whitecar, Charles Haas, V. K. Vaitkevicius, Barth Hoogstraten, Lance Heilbrun, 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer. A Southwest oncology group study Cancer. ,vol. 44, pp. 1215- 1221 ,(1979) , 10.1002/1097-0142(197910)44:4<1215::AID-CNCR2820440408>3.0.CO;2-S
I W F Hanham, K A Newton, G Westbury, Seventy-Five Cases of Solid Tumours Treated by a Modified Quadruple Chemotherapy Regime British Journal of Cancer. ,vol. 25, pp. 462- 478 ,(1971) , 10.1038/BJC.1971.59
Stephen Krauss, Takuo Sonoda, Alan Solomon, Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C Cancer. ,vol. 43, pp. 1598- 1603 ,(1979) , 10.1002/1097-0142(197905)43:5<1598::AID-CNCR2820430505>3.0.CO;2-Y
David A. Karnofsky, Meaningful clinical classification of therapeutic responses to anticancer drugs Clinical Pharmacology & Therapeutics. ,vol. 2, pp. 709- 712 ,(1961) , 10.1002/CPT196126709
R K Desser, M F Kozloff, C M Shapiro, J D Bitran, A A Billings, Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM). Cancer treatment reports. ,vol. 63, pp. 2049- 2051 ,(1979)